A new breakthrough in anti-aging research could lead to gene and stem cell therapies that turn back the hands of time.
Researchers at the University of Pittsburgh’s Center for Cellular and Molecular Engineering have developed a small bioreactor that grows constructs of bone and cartilage in a single chamber.
Gain access to free tools and resources from AABME, an initiative designed to stimulate biomedical innovation by bringing together and providing resources to the biomedical engineering community.
Regenerative medicine searches for ways to move into larger tests and commercial products.
A combined bioreactor and cell culture analyzer automatically monitors and adjusts growing conditions on 48 different cell cultures.
A new system may help solve the problem of shipping cells between laboratories and hospitals and clinics by developing an alternative to cryopreservation.
Engineering and manufacturing expertise could ease the shortage of viral vectors used for drug delivery in the booming gene therapy market.
In the wake of recent developments in the field of cell therapy, bioprinter vendors are seeking to market to more sophisticated researchers.
New technologies for engineering cells, monitoring cellular attributes and accelerating manufacturing lead to better and safer cell therapy products.
Light-activated nanoparticles make existing antibiotics more effective against heavily antibiotic-resistant microbes. The research is giving new life to existing drugs that lose their effectiveness against antibiotic-resistant microbes.
Light-activated nanoparticles make existing antibiotics more effective against heavily antibiotic-resistant microbes. The research is giving new life to existing drugs that lose their effectiveness against antibiotic-resistant microbes.
Scientists are now developing alternative strategies for producing new types of CAR-T treatments.
Encellin is working to eliminate insulin injections for diabetic patients with an insulin-producing implant containing live cells.
New classes of molecules based on naturally occurring sugars promise to preserve cryogenically frozen cells and perhaps organs without any of the toxic side effects of current treatment.
Risk of infection continues to be an issue across the healthcare arena. A Frost & Sullivan industry research study published in May 2017 reported that global revenue in the antimicrobial coating materials market stood at $700 million in 2016, and is poised to reach $1.1 billion by 2021.